William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
I tell you, we have an extraordinary group of investors who actually...you know, you'd be amazed at how many people say don't lose sight of what you all do well, which is embodied in our Credo, and we have investors that say that all the time to us and I get letters this time of the year, and right ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
